| 317 |
abnormal |
developmental process
(GO:0032502)
|
|
577: impaired, Development
|
| 444 |
occurrence |
Dilatation
(MESH:D004106)
|
renal tubule
(UBERON:0009773)
|
823: Occurrence, Cystic dilatation (renal tubule)
|
| 71 |
increased |
Disease Susceptibility
(MESH:D004198)
|
|
323: Increased, Disease susceptibility
|
| 72 |
increased |
DNA alkylation
(GO:0006305)
|
deoxyribonucleic acid
(CHEBI:16991)
|
97: Alkylation, DNA
|
| 224 |
abnormal |
DNA alkylation
(GO:0006305)
|
Nuclear deoxyribonucleic acid
(FMA:67194)
|
373: Formation, Pro-mutagenic DNA Adducts
|
| 860 |
increased |
DNA damage response, detection of DNA damage
(GO:0042769)
|
site of DNA damage
(GO:0090734)
|
2 Events
|
| 300 |
increased |
DNA hypermethylation
(GO:0044026)
|
|
662: Decreased testosterone by the fetal Leydig cells, Hypermethylation in the fetal testis
|
| 310 |
abnormal |
DNA repair
(GO:0006281)
|
Mitochondrial deoxyribonucleic acid
(FMA:67199)
|
664: Overwhelmed, Mitochondrial DNA repair mechanisms
|
| 1000 |
abnormal |
DNA repair
(GO:0006281)
|
deoxyribonucleic acid
(CHEBI:16991)
|
155: Inadequate DNA repair
|
| 670 |
increased |
DNA repair
(GO:0006281)
|
deoxyribonucleic acid
(CHEBI:16991)
|
1281: Increased, DNA Damage-Repair
|
| 74 |
functional change |
DNA repair
(GO:0006281)
|
deoxyribonucleic acid
(CHEBI:16991)
|
None
|
| 228 |
functional change |
DNA repair
(GO:0006281)
|
Nuclear deoxyribonucleic acid
(FMA:67194)
|
493: Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts
|
| 994 |
increased |
DNA Strand Break
(NCI:C25830)
|
Deoxyribonucleic acid
(FMA:74412)
|
1635: Increase, DNA strand breaks
|
| 661 |
abnormal |
DNA topoisomerase II activity
(GO:0061505)
|
|
1252: Binding to (interferes with) topoisomerase II enzyme
|
| 290 |
decreased |
dopamine beta-monooxygenase activity
(GO:0004500)
|
dopamine beta-hydroxylase
(PR:000006294)
|
526: Inhibition, Inhibition of Dopamine-beta-hydroxylase
|
| 13 |
decreased |
ecdysis-triggering hormone activity
(GO:0008255)
|
|
988: Decrease, Circulating ecdysis triggering hormone
|
| 750 |
decreased |
ecdysis, chitin-based cuticle
(GO:0018990)
|
|
1524: Increase, Premature molting
|
| 12 |
increased |
ecdysone receptor-mediated signaling pathway
(GO:0035076)
|
ecdysone receptor holocomplex
(GO:0008230)
|
103: Increase, Ecdysone receptor hyperactivation
|
| 736 |
occurrence |
EEG with focal epileptiform discharges
(HP:0011185)
|
neuron part
(GO:0097458)
|
None
|
| 737 |
occurrence |
EEG with focal epileptiform discharges
(HP:0011185)
|
neuron
(CL:0000540)
|
1623: Occurrence, Focal Seizure
|
| 109 |
decreased |
egg quantity
(VT:1000294)
|
|
2 Events
|
| 837 |
increased |
Elevated C-reactive protein level
(HP:0011227)
|
C-reactive protein
(PR:000005897)
|
1868: Hyperinflammation
|
| 684 |
abnormal |
embryo development
(GO:0009790)
|
|
1295: Defect of Embryogenesis
|
| 497 |
increased |
embryonic lethality
(MP:0008762)
|
|
947: Increase, Early Life Stage Mortality
|
| 1079 |
abnormal |
embryonic organ development
(GO:0048568)
|
penis
(UBERON:0000989)
|
2082: Hypospadias, increased
|